30 May 2024
Latham & Watkins Advises on Financing for GTCR’s US$627 Million Acquisition of Surmodics, Inc.
Advising firms
Deal team
11 lawyers named| Lawyer | Firm | Seniority | Practice | Office |
|---|---|---|---|---|
| Stelios Saffos Lead | Latham & Watkins LLP | Partner | finance and hybrid capital | Not stated |
| Peter Sluka Lead | Latham & Watkins LLP | Partner | finance and hybrid capital | Not stated |
| Michael Saliba Lead | Latham & Watkins LLP | Partner | finance and hybrid capital | Not stated |
| Zachary Judd Lead | Latham & Watkins LLP | Partner | finance and hybrid capital | Not stated |
| Marcela Ruenes | Latham & Watkins LLP | Counsel | finance and hybrid capital | Not stated |
| Christian DeSimone | Latham & Watkins LLP | Associate | finance and hybrid capital | Not stated |
| Ben Winnett | Latham & Watkins LLP | Associate | finance and hybrid capital | Not stated |
| Katherine Page | Latham & Watkins LLP | Associate | finance and hybrid capital | Not stated |
| Jiyeon Lee-Lim | Latham & Watkins LLP | Partner | tax | Not stated |
| Nicholas Sun | Latham & Watkins LLP | Associate | tax | Not stated |
| Brian Rock | Latham & Watkins LLP | Partner | uniform commercial code | Not stated |
Stated terms
- Stated value
- USD 627m (US$627 million)
- What the figure measures
- Total transaction value
- Client
- Not stated
- Counterparties
- GTCR (Buy-side)
Surmodics, Inc. (Target)